Bronchiectasis trials in Germany

In Germany 9 Also abroad 120

9 of 9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Where
Aachen, Ahrensburg, Bamberg, Berlin, Bochum, Bonn, Cologne, Donaustauf, Dortmund, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Gauting, Halle, Hanover, Heidelberg, Immenhausen, Jena, Kiel, Mainz, München, Münster, Potsdam, Stralstund, Wiesbaden
Age
12 years and over
People
1,755 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06872892 · EU 2024-518589-29-00
Phase 3Not yet taking people in Germany
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
Where
Aachen, Ahrensburg, Bamberg, Berlin, Bochum, Bonn, Cologne, Donaustauf, Dortmund, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Gauting, Halle, Hanover, Heidelberg, Jena, Kiel, Lübeck, Mainz, München, Münster, Potsdam, Stralstund, Wiesbaden
Age
12 years and over
People
1,500 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07915219 · EU 2026-527086-30-00
Phase 2Taking people
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
Where
Berlin, Cologne, Hanover
Age
18 years to 80 years
People
300 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07720375 · EU 2026-525524-18-00
No phaseTaking people
Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
Where
Aachen, Lübeck, München
Age
18 years and over
People
468 worldwide
Run by
Physio-Assist
See details and how to joinNCT06487273
Phase 2Taking people
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
Where
Ahrensburg, Berlin, Dresden, Frankfurt am Main, Frankfurt Am Main, Jena, Luebeck, Mainz, Munich
Age
18 years to 85 years
People
180 worldwide
Run by
CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00
Phase 2Taking people
Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept - randomized controlled trial
Where
Berlin, Cologne, Duesseldorf, Essen, Frankfurt Am Main, Hanover, Loewenstein, Luebeck, Marburg, Munich, Stuttgart, Wangen Im Allgaeu
Age
18 years and over
People
66
Run by
Philipps-Universitaet Marburg
See details and how to join2023-509277-22-00
Phase 2Taking people
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Where
Berlin, Darmstadt, Essen, Frankfurt, Halle, Hanover, Konstanz, München, München-Pasing
Age
12 years and over
People
435 worldwide
Run by
AstraZeneca
See details and how to joinNCT07088926
Phase 2Taking people
A trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and chronic PsA colonization
Where
Berlin, Essen, Frankfurt am Main, Halle, Hanover, Konstanz, München, Munich
Age
18 years and over
People
112 worldwide
Run by
AstraZeneca AB
See details and how to join2025-523009-14-00
Phase 2Taking people
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Where
Bendorf, Berlin, Cologne, Essen, Frankfurt am Main, Geesthacht, Hamburg, München
Age
18 years to 85 years
People
363 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07201051 · EU 2025-522892-27-00